(ACT) Enact Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29249E1091
ACT: Mortgage Insurance, Underwriting Services, Reinsurance Products
Enact Holdings, Inc. (NASDAQ: ACT) is a leading private mortgage insurance company in the United States, specializing in residential mortgage guaranty insurance. The company provides a range of products, including prime-based, individually underwritten residential mortgage insurance, contract underwriting services for lenders, and mortgage-related reinsurance products. Enact primarily serves residential mortgage loan originators. Formerly known as Genworth Mortgage Holdings, Inc., the company rebranded as Enact Holdings, Inc. in May 2021. Founded in 1981 and headquartered in Raleigh, North Carolina, Enact operates as a subsidiary of Genworth Holdings, Inc. For more information, visit their website at https://enactmi.com.
Enacts core operations involve underwriting and assuming residential mortgage guaranty insurance, which protects lenders from potential defaults. Their services also extend to contract underwriting, where they handle the underwriting process for mortgage lenders, and offering reinsurance products to manage risk. This comprehensive approach positions Enact as a key player in the mortgage insurance industry, supporting lenders and borrowers alike in the U.S. housing market.
With a market capitalization of $5.35 billion, Enact demonstrates financial stability. The companys price-to-earnings (P/E) ratio stands at 8.06, with a forward P/E of 8.18, indicating moderate valuation relative to earnings expectations. The price-to-book (P/B) ratio of 1.07 suggests that the stock is valued near its book value, while the price-to-sales (P/S) ratio of 4.45 reflects a premium on revenue. Enacts return on equity (RoE) of 13.77% highlights efficient profitability.
Enacts stock (NASDAQ: ACT) shows a 20-day average volume of 466,114 shares, with a last price of $34.86. The stocks short-term trend is indicated by a 20-day moving average of $34.59, while the 50-day moving average is $34.07, and the 200-day moving average is $33.95. The Average True Range (ATR) of 1.01 signals moderate volatility, suggesting potential price swings in the near term.
Over the next three months, Enacts stock price may experience fluctuations influenced by its moving averages and volatility. The stock is currently trading above its 50-day and 200-day moving averages, which could indicate bullish sentiment. However, the 20-day moving average slightly above the 50-day average suggests a potential consolidation phase. The ATR of 1.01 indicates that price movements may remain within a narrow range, with possible support around $33.95 and resistance near $35.50.
From a fundamental perspective, Enacts P/E ratio of 8.06 and forward P/E of 8.18 suggest that the market expects stable earnings growth. The P/B ratio of 1.07 indicates that the stock is fairly valued relative to book value, while the P/S ratio of 4.45 reflects a premium on revenue. The companys RoE of 13.77% underscores strong profitability, which could support further growth. Overall, Enacts fundamentals suggest a stable outlook with potential for moderate appreciation.
Additional Sources for ACT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ACT Stock Overview
| Market Cap in USD | 5,350m |
| Sector | Financial Services |
| Industry | Insurance - Specialty |
| GiC Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 2021-09-16 |
ACT Stock Ratings
| Growth Rating | 74.3 |
| Fundamental | 68.7 |
| Dividend Rating | 32.8 |
| Rel. Strength | 0.33 |
| Analysts | 3.6/5 |
| Fair Price Momentum | 38.15 USD |
| Fair Price DCF | 99.63 USD |
ACT Dividends
| Dividend Yield 12m | 2.13% |
| Yield on Cost 5y | 4.42% |
| Annual Growth 5y | -6.38% |
| Payout Consistency | 89.9% |
ACT Growth Ratios
| Growth Correlation 3m | 61.6% |
| Growth Correlation 12m | 46.4% |
| Growth Correlation 5y | 96.5% |
| CAGR 5y | 23.34% |
| CAGR/Max DD 5y | 1.15 |
| Sharpe Ratio 12m | 1.09 |
| Alpha | 14.57 |
| Beta | 0.564 |
| Volatility | 23.26% |
| Current Volume | 466.1k |
| Average Volume 20d | 474.1k |
As of May 01, 2025, the stock is trading at USD 35.79 with a total of 466,145 shares traded.
Over the past week, the price has changed by +1.59%, over one month by +2.99%, over three months by +6.54% and over the past year by +23.10%.
Yes, based on ValueRay Fundamental Analyses, Enact Holdings (NASDAQ:ACT) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.71 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACT as of May 2025 is 38.15. This means that ACT is currently overvalued and has a potential downside of 6.59%.
Enact Holdings has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold ACT.
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ACT Enact Holdings will be worth about 41.9 in May 2026. The stock is currently trading at 35.79. This means that the stock has a potential upside of +17.07%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 38.2 | 6.7% |
| Analysts Target Price | 38.6 | 7.9% |
| ValueRay Target Price | 41.9 | 17.1% |